Concepedia

Carlos Martín Loza

CM

Statistics

Publications

3

Citations

115

H-Index

3

Active since

2012

Affiliations

Instituto Alexander Fleming(Current)

Fundación Instituto Leloir

Fundación para la Investigación, Docencia y Prevención del Cáncer

Carlos Martín Loza is an author at Instituto Alexander Fleming specializing in immunology, cell biology, and immunotherapy.

Top concepts

Publications per year

2012–2018

3

Publications

3

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

María P. Roberti, Yamila Rocca, Mora Amat et al. · Breast Cancer Research and Treatment · 2012 · 52 citations

, , +8

Overexpression of CD85j in TNBC patients inhibits Cetuximab‐mediated NK‐cell ADCC but can be restored with CD85j functional blockade

María P. Roberti, Estefanía P. Juliá, Yamila Rocca et al. · European Journal of Immunology · 2015 · 49 citations · Full text

High neutrophil to lymphocyte ratio and decreased CD69<sup>+</sup>NK cells represent a phenotype of high risk in early-stage breast cancer patients

Pablo Mandó, Manglio Rizzo, María Paula Roberti et al. · OncoTargets and Therapy · 2018 · 14 citations · Full text

1–3 of 3